Compounds > n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine
Page last updated: 2024-09-03

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and wogonin

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with wogonin in 1 studies

Compound Research Comparison

Studies
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Trials
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Recent Studies (post-2010)
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Studies
(wogonin)		Trials
(wogonin)		Recent Studies (post-2010) (wogonin)
791164920320

Protein Interaction Comparison

ProteinTaxonomyn-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50)wogonin (IC50)
Lysine-specific histone demethylase 1AHomo sapiens (human)8.87
Cyclin-T1Homo sapiens (human)0.1927
Pyruvate kinase PKMHomo sapiens (human)2.01
Cyclin-A2Homo sapiens (human)1.46
Cyclin-CHomo sapiens (human)5.9
Cyclin-dependent kinase 2Homo sapiens (human)1.46
Nitric oxide synthase, inducibleMus musculus (house mouse)7.8
Prostaglandin G/H synthase 2Homo sapiens (human)1.46
Cyclin-dependent kinase 8Homo sapiens (human)5.9
Cyclin-dependent kinase 9Homo sapiens (human)0.192
Prostaglandin G/H synthase 2Mus musculus (house mouse)1.07

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and wogonin

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012